These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2189903)

  • 1. Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension.
    Weir MR; Vlachkis ND; DeQuattro V; Douglas J; Svetkey LP; Singh S; Wiedl SC; Chen CF; Woodward DL; Saunders E
    J Clin Pharmacol; 1990 May; 30(5):425-37. PubMed ID: 2189903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tolerability of nilvadipine compared to nifedipine in patients with essential hypertension.
    Faust G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S56-61. PubMed ID: 1283191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nilvadipine in hypertension--experience in ambulatory treatment.
    Hoffmann A; Kraul H; Burkardt I
    Int J Clin Pharmacol Ther; 1997 May; 35(5):195-203. PubMed ID: 9174874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of nilvadipine and nitrendipine on circadian blood pressure.
    Keck M
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S43-9. PubMed ID: 1283188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G;
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of once-daily nilvadipine with enalapril and diuretic in patients with essential hypertension.
    Fritschka E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S62-8. PubMed ID: 1283192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of nilvadipine on diurnal blood pressure profile. Use of a new calcium channel blocker in mild to intermediate hypertension].
    Keck M; Quitzdorff G
    Fortschr Med; 1992 Aug; 110(24):444-6. PubMed ID: 1398392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of rifampicin on the pharmacokinetics and pharmacodynamics of orally administered nilvadipine to healthy subjects.
    Saima S; Furuie K; Yoshimoto H; Fukuda J; Hayashi T; Echizen H
    Br J Clin Pharmacol; 2002 Feb; 53(2):203-6. PubMed ID: 11851646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nilvadipine in hypertension with renal dysfunction.
    Berger HH; Albert FW
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S73-9. PubMed ID: 1283194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation between the hypotensive effect of increasing single doses of nifedipine tablets with its plasma concentration in patients with essential hypertension.
    Streifler JY; Zyber-Katz E; Rosenfeld JB
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):657-61. PubMed ID: 3912333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of nilvadipine on nifedipine-induced edema of the lower leg. Results of a double-blind randomized comparative study].
    Vollmuth M; Schmitt W
    Fortschr Med; 1994 Jun; 112(18):266-70. PubMed ID: 8088691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-step treatment of mild to moderate uncomplicated essential hypertension by a new calcium antagonist: nicardipine.
    Bellet M; Loria Y; Lallemand A
    J Cardiovasc Pharmacol; 1985; 7(6):1149-53. PubMed ID: 2418302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-hour blood pressure control after single daily doses of nivaldipine in patients with essential hypertension.
    Lossnitzer K; Huber HJ; Kuchlbauer R; Quitzdorff G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S35-42. PubMed ID: 1283187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
    Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Goldberger J; Kimmel B; Stroh J; Dorsa F; Allen L; Strom J
    Am J Cardiol; 1985 Dec; 56(16):41H-46H. PubMed ID: 3934948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine decreases antihypertensive effect of nilvadipine.
    Yasui-Furukori N; Tateishi T
    J Clin Pharmacol; 2002 Jan; 42(1):100-3. PubMed ID: 11808819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A randomized double-blind therapeutic trial of enalapril versus timed-release nifedipine in mild to moderate essential hypertension].
    Artigou JY; Benichou M; Berland J; Fressinaud P; Grollier G; Guéret P; Nguyen Cong Duc L
    Presse Med; 1990 Jan 6-13; 19(1):13-6. PubMed ID: 2137218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily amlodipine in the treatment of mild to moderate hypertension.
    Webster J; Robb OJ; Jeffers TA; Scott AK; Petrie JC
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S72-5. PubMed ID: 2467134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
    Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S
    Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.